Background
Background Studies using computer Studies using computer databases suggestthat atypical antidatabases suggestthat atypical antipsychotic agents are more likely to be psychotic agents are more likely to be associated with diabetes than are convenassociated with diabetes than are conventional drugs. tional drugs.
Aims Aims To discover the extent of testing
To discover the extent of testing for diabetes mellitus in hospital in-patients for diabetes mellitus in hospital in-patients prescribed antipsychotics. prescribed antipsychotics.
Method Method Prescription charts were
Prescription charts were screened to identify patients prescribed screened to identify patients prescribed antipsychotics.Case notes were then antipsychotics.Case notes were then searched for evidence of testing for searched for evidence of testing for diabetes. diabetes.
Results

In all, 606 patients were preIn all, 606 patients were prescribed antipsychotics, of whom 250 scribed antipsychotics, of whom 250 (41.3%) had evidence of prior testing for (41.3%) had evidence of prior testing for diabetes. Patients prescribed atypicals diabetes. Patients prescribed atypicals were were 40% more likely to have been tested 40% more likely to have been tested than those prescribed conventional drugs than those prescribed conventional drugs (RR (RR ¼1.4,95% CI1.1^1.9). Adjusted odds 1.4,95% CI1.1^1.9). Adjusted odds ratios ratios v v. conventional antipsychotics for . conventional antipsychotics for testing were signifi testing were significantlyhigher for cantlyhigher for clozapine (OR clozapine (OR¼ 4.64, 95% 4.64,95% CI 2.42^8.90), CI 2.42^8.90), olanzapine (OR olanzapine (OR¼1.85, 95% CI1.04^3.30) 1.85, 95% CI1.04^3.30) and antipsychotic polypharmacy (OR and antipsychotic polypharmacy (OR¼ 2.96,95% CI1.59^5.52). 2.96,95% CI1.59^5.52).
Conclusions Conclusions Testing for diabetes was
Testing for diabetes was undertaken in less than half of the patients undertaken in less than half of the patients studied.Testing was more common in studied.Testing was more common in those receiving atypical antipsychotics. those receiving atypical antipsychotics. Apparent differences in claimed causal Apparent differences in claimed causal association of the use of some antiassociation of the use of some antipsychotics with diabetes may in part psychotics with diabetes may in part reflect different rates of testing. reflect different rates of testing.
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Diabetes mellitus is a growing health proDiabetes mellitus is a growing health problem in developed countries, where its blem in developed countries, where its prevalence has risen substantially in the prevalence has risen substantially in the past two decades (Mokdad past two decades (Mokdad et al et al, 2000) . , 2000) . This clearly has important consequences This clearly has important consequences for health care resource use and for life for health care resource use and for life expectancy (Beckman expectancy . Even a , 2002) . Even a moderately elevated plasma glucose conmoderately elevated plasma glucose concentration is a continuous risk factor for centration is a continuous risk factor for myocardial infarction (Gerstein, 1999) . myocardial infarction (Gerstein, 1999) .
The prevalence of diabetes mellitus The prevalence of diabetes mellitus appears to be relatively high in schizoappears to be relatively high in schizophrenia (Mukherjee phrenia (Mukherjee et al et al, 1996; Cassidy , 1996; Cassidy et et al al, 1999) and bipolar disorder (Dixon , 1999) and bipolar disorder (Dixon et et al al, 2000) . Indeed, an association between , 2000). Indeed, an association between psychotic disorders and diabetes mellitus psychotic disorders and diabetes mellitus has long been suspected, and pre-dates the has long been suspected, and pre-dates the widespread use of antipsychotic drugs widespread use of antipsychotic drugs (Braceland (Braceland et al et al, 1946; Freeman, 1946 Freeman, ). , 1946 Freeman, 1946) . The introduction of conventional antiThe introduction of conventional antipsychotic drugs appeared to increase psychotic drugs appeared to increase still further the prevalence of diabetes still further the prevalence of diabetes among people with psychotic disorders among people with psychotic disorders (Thonnard-Neumann, 1967) , and the link (Thonnard-Neumann, 1967) , and the link between the use of these drugs and diabetes between the use of these drugs and diabetes became well established (Proakis became well established (Proakis et al et al, , 1971 ). However, knowledge of this associa-1971). However, knowledge of this association seems to have dissipated to such an extion seems to have dissipated to such an extent that widely used reference texts now tent that widely used reference texts now do not list diabetes as a possible adverse do not list diabetes as a possible adverse effect of chlorpromazine (British Medical effect of chlorpromazine (British Medical Association & Royal Pharmaceutical Association & Royal Pharmaceutical Society Society of Great Britain, 2004) . In recent of Great Britain, 2004) . In recent years the use of atypical antipsychotics years the use of atypical antipsychotics has been strongly linked to emergent diahas been strongly linked to emergent diabetes and diabetic ketoacidosis (Mir & betes and diabetic ketoacidosis (Mir & Taylor, 2001) . Several database studies Taylor, 2001) . Several database studies have now established that atypical antipsyhave now established that atypical antipsychotics such as clozapine and olanzapine chotics such as clozapine and olanzapine are more likely to be associated with a diagare more likely to be associated with a diagnosis of diabetes than are conventional nosis of diabetes than are conventional drugs (Gianfrancesco drugs (Gianfrancesco et al et al, 2002; Koro , 2002; Koro et al et al, 2002; Sernyak , 2002; Sernyak et al et al, 2002) . , 2002). It is important to note that the results of It is important to note that the results of such studies do not directly implicate atypisuch studies do not directly implicate atypical antipsychotics as drugs relatively more cal antipsychotics as drugs relatively more likely to likely to cause cause diabetes. Rates of diagnosis diabetes. Rates of diagnosis reported in these studies are dependent reported in these studies are dependent on screening or monitoring for (and, on screening or monitoring for (and, ultimately, identification of) diabetes. It is ultimately, identification of) diabetes. It is possible that the observed higher rate of possible that the observed higher rate of diabetes seen with atypical drugs is at least diabetes seen with atypical drugs is at least in part a reflection of a relatively greater in part a reflection of a relatively greater intensity intensity of monitoring for diabetes when of monitoring for diabetes when these drugs are prescribed. Such differences these drugs are prescribed. Such differences in monitoring practice might be expected, in monitoring practice might be expected, given the highly publicised link between atygiven the highly publicised link between atypical antipsychotic drugs and diabetes and pical antipsychotic drugs and diabetes and the absence of such warnings related to conthe absence of such warnings related to conventional drugs in prescribers' reference ventional drugs in prescribers' reference books. books.
Little is known of the frequency of diaLittle is known of the frequency of diabetes testing in patients with schizophrenia betes testing in patients with schizophrenia or related disorders or in those receiving or related disorders or in those receiving antipsychotic treatment. We undertook a antipsychotic treatment. We undertook a survey of the extent of diagnostic testing survey of the extent of diagnostic testing for diabetes in a cohort of hospitalised for diabetes in a cohort of hospitalised patients receiving a variety of antipsychotic patients receiving a variety of antipsychotic medications. medications. All in-patient prescription charts were All in-patient prescription charts were reviewed in order to identify patients prereviewed in order to identify patients prescribed antipsychotic medication. From scribed antipsychotic medication. From these, patients prescribed the same antithese, patients prescribed the same antipsychotic as a regular prescription for at psychotic as a regular prescription for at least 1 week were identified and included least 1 week were identified and included in the study. in the study.
METHOD METHOD
Case notes for all patients in the study Case notes for all patients in the study were examined (by C.Y. and R.E.) to were examined (by C.Y. and R.E.) to obtain demographic data and diagnosis, obtain demographic data and diagnosis, and to determine whether investigations and to determine whether investigations that would have enabled diagnosis of that would have enabled diagnosis of impaired fasting glucose, impaired glucose impaired fasting glucose, impaired glucose tolerance or diabetes mellitus had taken tolerance or diabetes mellitus had taken place. These investigations included meaplace. These investigations included measurements of fasting plasma glucose, surements of fasting plasma glucose, random plasma glucose and glycosylated random plasma glucose and glycosylated haemoglobin (HbA haemoglobin (HbA 1c 1c ) and oral glucose tol-) and oral glucose tolerance tests. Case note documentation of erance tests. Case note documentation of any one of these tests conducted at any time any one of these tests conducted at any time was considered to be evidence of diagnostic was considered to be evidence of diagnostic testing for diabetes. Recorded diagnoses of testing for diabetes. Recorded diagnoses of diabetes mellitus, impaired glucose tolerdiabetes mellitus, impaired glucose tolerance or impaired fasting glucose, or ance or impaired fasting glucose, or prescription of oral hypoglycaemics or prescription of oral hypoglycaemics or insulin, were also considered to be evidence insulin, were also considered to be evidence of prior testing for diabetes. Case notes of prior testing for diabetes. Case notes contained handwritten entries from medical contained handwritten entries from medical and nursing staff, correspondence, chemical and nursing staff, correspondence, chemical pathology reports and previous prescription pathology reports and previous prescription charts. All volumes of case notes available charts. All volumes of case notes available on the ward at the time of the data retrieval on the ward at the time of the data retrieval exercise were examined. exercise were examined.
Prevalence of glycaemic disorders was Prevalence of glycaemic disorders was determined by standard diagnostic criteria. determined by standard diagnostic criteria. Impaired fasting glucose was diagnosed if Impaired fasting glucose was diagnosed if the fasting plasma glucose level exceeded the fasting plasma glucose level exceeded 6.1 mmol/l but was less than 7.0 mmol/l. 6.1 mmol/l but was less than 7.0 mmol/l. Impaired glucose tolerance was diagnosed Impaired glucose tolerance was diagnosed if plasma glucose levels were greater than if plasma glucose levels were greater than 7.8 mmol/l but less than 11.1 mmol/l 2 h 7.8 mmol/l but less than 11.1 mmol/l 2 h after glucose challenge. Diabetes mellitus after glucose challenge. Diabetes mellitus was diagnosed if a random plasma glucose was diagnosed if a random plasma glucose test exceeded 11.1 mmol/l, if a fasting test exceeded 11.1 mmol/l, if a fasting plasma glucose test exceeded 7.0 mmol/l or plasma glucose test exceeded 7.0 mmol/l or if HbA if HbA 1c 1c exceeded 9% (National Diabetes exceeded 9% (National Diabetes Data Group, 1979; Lebovitz, 2001) . Data Group, 1979; Lebovitz, 2001) . Patients falling into more than one category Patients falling into more than one category on different measures were given a diagnosis on different measures were given a diagnosis of diabetes mellitus. Apparent prevalence of diabetes mellitus. Apparent prevalence rates were calculated by comparing the rates were calculated by comparing the numbers diagnosed with the disorder with numbers diagnosed with the disorder with the number of the total sample. Statistical the number of the total sample. Statistical analysis was performed using the Statistical analysis was performed using the Statistical Package for the Social Sciences, version 10 Package for the Social Sciences, version 10 for PC. for PC.
RESULTS RESULTS
Demographic factors Demographic factors
In total, 606 patients satisfying inclusion In total, 606 patients satisfying inclusion criteria were identified. Of these, 250 criteria were identified. Of these, 250 (41.3%) had documented evidence of (41.3%) had documented evidence of testing for diabetes. Demographic details testing for diabetes. Demographic details of the sample are given in Table 1 . of the sample are given in Table 1 
Testing and prescribed Testing and prescribed antipsychotic antipsychotic
The extent of testing of patients receiving The extent of testing of patients receiving different antipsychotic drugs is given in different antipsychotic drugs is given in Table 2 . There was a statistically sig- Table 2 . There was a statistically significant association between testing for nificant association between testing for diabetes and the antipsychotic received diabetes and the antipsychotic received
.f.¼5, 5, P P¼0.008). 0.008). Overall, 389 patients received an atypical Overall, 389 patients received an atypical antipsychotic drug as their sole antiantipsychotic drug as their sole antipsychotic treatment. Of these, 168 psychotic treatment. Of these, 168 (43.2%) were tested for diabetes. The risk (43.2%) were tested for diabetes. The risk ratio for testing was 1.4 (95% CI 1.1-1.9; ratio for testing was 1.4 (95% CI 1.1-1.9; P P¼0.005), compared with testing in pa-0.005), compared with testing in patients receiving conventional antipsychotics. tients receiving conventional antipsychotics.
Prevalence of glycaemic disorder Prevalence of glycaemic disorder
Of the 250 patients tested, 2 were classified Of the 250 patients tested, 2 were classified as having impaired fasting glucose and 37 as having impaired fasting glucose and 37 as having diabetes mellitus; the remaining as having diabetes mellitus; the remaining 211 patients had no evidence of a disorder 211 patients had no evidence of a disorder of glucose homoeostasis (test results norof glucose homoeostasis (test results normal). None was diagnosed with impaired mal). None was diagnosed with impaired glucose tolerance. Thus, 39 patients had glucose tolerance. Thus, 39 patients had evidence of glucose homoeostasis disorder, evidence of glucose homoeostasis disorder, a prevalence of 15.6% in those tested. a prevalence of 15.6% in those tested. The apparent prevalence of glucose homoThe apparent prevalence of glucose homoeostasis disorder in the total study popueostasis disorder in the total study population (based on number of diagnosed lation (based on number of diagnosed cases) was 6.4% (39 of 606). The numbers cases) was 6.4% (39 of 606). The numbers of diagnosed cases for each drug treatment of diagnosed cases for each drug treatment are shown in Table 3 . Prevalence of gluare shown in 
Duration of antipsychotic Duration of antipsychotic treatment treatment
The duration of treatment with the antiThe duration of treatment with the antipsychotic prescribed at the time of the psychotic prescribed at the time of the study was determined for 579 patients study was determined for 579 patients (96% Table 4 . different drugs is shown in Table 4 .
Odds of testing for diabetes Odds of testing for diabetes
Because likelihood of testing was associated Because likelihood of testing was associated with factors other than drug prescribed, we with factors other than drug prescribed, we calculated adjusted odds ratios for diabetes calculated adjusted odds ratios for diabetes testing for the different drug treatments testing for the different drug treatments (compared with testing for conventional (compared with testing for conventional antipsychotics), taking into account age, antipsychotics), taking into account age, gender, ethnicity, diagnosis and duration gender, ethnicity, diagnosis and duration of treatment (Table 5) . of treatment (Table 5) .
DISCUSSION DISCUSSION
The two major findings of this study The two major findings of this study are that testing for diabetes had been are that testing for diabetes had been undertaken in less than half of the patients undertaken in less than half of the patients receiving antipsychotics and that testing receiving antipsychotics and that testing was more frequently done in those receivwas more frequently done in those receiving atypical antipsychotics than in those ing atypical antipsychotics than in those receiving conventional drugs. These findreceiving conventional drugs. These findings have important consequences for ings have important consequences for the interpretation of diabetes prevalence the interpretation of diabetes prevalence studies using health care databases. studies using health care databases.
Consequences Consequences
The major consequence of testing such a The major consequence of testing such a small proportion of patients is that the small proportion of patients is that the overall prevalence of diabetes mellitus is overall prevalence of diabetes mellitus is likely to be underestimated. Nearly threelikely to be underestimated. Nearly threefifths of patients had never been tested for fifths of patients had never been tested for diabetes, and it is likely that this conceals diabetes, and it is likely that this conceals a number of patients with undiagnosed disa number of patients with undiagnosed disease. This supposition is supported by a ease. This supposition is supported by a study showing high rates of hyperglycaemia study showing high rates of hyperglycaemia and diabetes mellitus in patients receiving and diabetes mellitus in patients receiving clozapine who had no previous diagnosis clozapine who had no previous diagnosis of diabetes (Sernyak of diabetes (Sernyak et al et al, 2003) . This is , 2003). This is likely to mean that many cases of diabetes likely to mean that many cases of diabetes will go unnoticed and untreated, with will go unnoticed and untreated, with serious or even fatal consequences for serious or even fatal consequences for patients. In this study cohort, it is possible patients. In this study cohort, it is possible that those with symptoms or risk factors that those with symptoms or risk factors for diabetes were tested for the disorder for diabetes were tested for the disorder but those considered not to be at risk were but those considered not to be at risk were not tested. Fewer cases of diabetes would not tested. Fewer cases of diabetes would then have been missed. It is also important then have been missed. It is also important to note that 63 patients had received the to note that 63 patients had received the antipsychotic prescribed at the time of the antipsychotic prescribed at the time of the study for less than 1 month (although many study for less than 1 month (although many had received other antipsychotics before) -had received other antipsychotics before) -a period during which drug-induced diaa period during which drug-induced diabetes might not be expected. Although betes might not be expected. Although these factors are worthwhile considerations these factors are worthwhile considerations 
Variation in testing Variation in testing
The variation in the extent of testing for The variation in the extent of testing for diabetes with the type of antipsychotic diabetes with the type of antipsychotic prescribed suggests that its diagnosis might prescribed suggests that its diagnosis might be more likely in some patients at least be more likely in some patients at least partly because of more intensive testing. partly because of more intensive testing. In this study, testing was significantly more In this study, testing was significantly more likely to have occurred in patients taking likely to have occurred in patients taking clozapine, more than one antipsychotic clozapine, more than one antipsychotic drug and atypical drugs in general. Testing drug and atypical drugs in general. Testing was numerically more frequent in all was numerically more frequent in all patients receiving individual atypical drugs patients receiving individual atypical drugs compared with those receiving convencompared with those receiving conventional drugs. This occurred despite the tional drugs. This occurred despite the mean treatment duration being longer with mean treatment duration being longer with conventional drugs than with all other conventional drugs than with all other agents except clozapine. Indeed, adjusted agents except clozapine. Indeed, adjusted odds of testing, taking into account all odds of testing, taking into account all other influencing factors, were significantly other influencing factors, were significantly higher for clozapine, olanzapine and polyhigher for clozapine, olanzapine and polypharmacy. Although these findings suggest pharmacy. Although these findings suggest clinicians are now aware of the risk of clinicians are now aware of the risk of diabetes with atypical antipsychotics, diabetes with atypical antipsychotics, differential use of testing will inevitably differential use of testing will inevitably mean that the overall prevalence of diabetes mean that the overall prevalence of diabetes is likely to be underestimated to a greater is likely to be underestimated to a greater extent in those prescribed conventional extent in those prescribed conventional rather than atypical antipsychotics. This is rather than atypical antipsychotics. This is amply demonstrated by the differences in amply demonstrated by the differences in prevalence figures between those tested prevalence figures between those tested and in the total sample (see Table 3 ): and in the total sample (see Table 3 ): apparent prevalence figures conceal major apparent prevalence figures conceal major differences in diabetes prevalence. differences in diabetes prevalence. (2003) , other clinical environments (e.g. primary care) and other countries, then primary care) and other countries, then interpretation of the results of database interpretation of the results of database studies must inevitably be modified. The studies must inevitably be modified. The message from these studies (Gianfrancesco message from these studies (Gianfrancesco et al et al, 2002 (Gianfrancesco et al et al, , 2003 Koro , 2002 Koro , , 2003 Koro et al et al, 2002; Sernyak , 2002; Sernyak et al et al, 2002) is that diabetes mellitus is more , 2002) is that diabetes mellitus is more frequently associated with atypical antifrequently associated with atypical antipsychotic therapy than with conventional psychotic therapy than with conventional drugs; the implication is that atypical drugs drugs; the implication is that atypical drugs are relatively more likely to cause diabetes. are relatively more likely to cause diabetes. This may only be assumed, however, if the This may only be assumed, however, if the intensity of testing is similar for all drugs. intensity of testing is similar for all drugs. None of the studies cited above measured None of the studies cited above measured screening rates and few mentioned this screening rates and few mentioned this factor as a possible confounding variable. factor as a possible confounding variable. Few accounted for other possible influences Few accounted for other possible influences such as age, ethnicity, diagnosis and such as age, ethnicity, diagnosis and duration of treatment. So, it is entirely duration of treatment. So, it is entirely possible that database studies of antipsypossible that database studies of antipsychotics and diabetes mellitus inadvertently chotics and diabetes mellitus inadvertently overestimate the differences in causal assooverestimate the differences in causal association between individual antipsychotics, ciation between individual antipsychotics, and may erroneously link relatively higher and may erroneously link relatively higher rates of diabetes with atypical drugs. rates of diabetes with atypical drugs.
Comparison with prior studies Comparison with prior studies
Also of note in our study is the relaAlso of note in our study is the relatively higher prevalence of documented tively higher prevalence of documented testing among White patients and patients testing among White patients and patients with bipolar disorder. Only 36% (82 of with bipolar disorder. Only 36% (82 of 228) of participants of Black African des-228) of participants of Black African descent had been tested and only 37% (155 cent had been tested and only 37% (155 of 419) of those with schizophrenia or of 419) of those with schizophrenia or schizoaffective disorder. These are importschizoaffective disorder. These are important and damning observations, given the ant and damning observations, given the high risk of diabetes in these patient groups. high risk of diabetes in these patient groups.
None the less, it is possible that our None the less, it is possible that our method provided an incomplete view of method provided an incomplete view of testing for diabetes in these patients. We testing for diabetes in these patients. We searched all case notes available on hospital searched all case notes available on hospital wards at the time of our visit. Many wards at the time of our visit. Many patients have several volumes of case notes patients have several volumes of case notes and it is possible that some volumes were and it is possible that some volumes were missing from the ward. We cannot discount missing from the ward. We cannot discount the possibility that some patients had the possibility that some patients had undergone tests for diabetes and that the undergone tests for diabetes and that the results of these tests appeared in missing results of these tests appeared in missing case notes and were not alluded to in notes case notes and were not alluded to in notes available to us. Tests might also have been available to us. Tests might also have been conducted and recorded in the community. conducted and recorded in the community. It is unlikely, however, that a diagnosis of It is unlikely, however, that a diagnosis of diabetes mellitus would be concealed in diabetes mellitus would be concealed in this way, since once recorded either in this way, since once recorded either in hospital or general practice notes the diaghospital or general practice notes the diagnosis would be likely to be mentioned in nosis would be likely to be mentioned in correspondence or case histories contained correspondence or case histories contained in current notes available to us. Moreover, in current notes available to us. Moreover, data collected on duration of treatment data collected on duration of treatment indirectly indicate the substantial length of indirectly indicate the substantial length of time covered by our case note search. time covered by our case note search.
In conclusion, testing for diabetes in In conclusion, testing for diabetes in patients prescribed antipsychotics was patients prescribed antipsychotics was incomplete. The paucity of testing for a incomplete. The paucity of testing for a condition that has considerable morbidity condition that has considerable morbidity and that is strongly associated with and that is strongly associated with 
